InsiderGauge
Checking updates…
Dashboard

Kirn Davidinsider trades

In SEC Form 4 filings, Kirn David is listed as See Remarks of 4D Molecular Therapeutics, Inc. (FDMT). In the last 90 days, Kirn David sold $2.65M of 4D Molecular Therapeutics, Inc. (FDMT) on the open market and bought none. All 5 sales were reported under a 10b5-1 trading plan.

Companies and roles

CompanyRoleTransactionsLast filed
FDMT4D Molecular Therapeutics, Inc.See Remarks7Oct 7

Cluster buys

No cluster buy in the last 90 days included a purchase by this insider (two or more insiders buying within 14 days).

Form 4 historysince 2026-08-21

CompanyTradedFiledTypeSharesPriceValueOwned after10b5-1 planFiling
FDMT4D Molecular Therapeutics, Inc.Oct 5Oct 7S58,061$12.92Sale −$750,235709,425YesForm 4
FDMT4D Molecular Therapeutics, Inc.Oct 5Oct 7S272$13.61Sale −$3,702709,153YesForm 4
FDMT4D Molecular Therapeutics, Inc.Sep 14Sep 16S58,333$13.90Sale −$811,004767,486YesForm 4
FDMT4D Molecular Therapeutics, Inc.Aug 19Aug 21M50,000$4.14$207,000894,895YesForm 4
FDMT4D Molecular Therapeutics, Inc.Aug 19Aug 21S43,149$15.36Sale −$662,622851,746YesForm 4
FDMT4D Molecular Therapeutics, Inc.Aug 19Aug 21S25,927$16.42Sale −$425,651825,819YesForm 4
FDMT4D Molecular Therapeutics, Inc.Aug 19Aug 21M · derivative50,000$4.14$207,000217,500YesForm 4

Published from this insider's public Form 4 filings on SEC EDGAR; the name is shown as filed. Named in a filing and want this page removed? See the privacy policy.